Literature DB >> 9749580

Mitochondrial dysfunction in Parkinson's disease.

Y Mizuno1, H Yoshino, S Ikebe, N Hattori, T Kobayashi, S Shimoda-Matsubayashi, H Matsumine, T Kondo.   

Abstract

This review discusses the etiology and pathogenesis of Parkinson's disease (PD). Mitochondrial respiratory failure and oxidative stress appear to be two major contributors to nigral neuronal death in PD. Complex I deficiency has been reported by several groups and appears to be one of the basic abnormalities responsible for mitochondrial failure. The principal question is whether or not complex I deficiency is primary or secondary. The second question is whether or not complex I deficiency is localized in the nigrostriatal system or is systemically present. It is our impression that complex I deficiency is not the primary cause but that its deficiency appears to be systemic. The primary cause may be the combination of genetic background and potential nigral neurotoxins. Exposure of nigral neurons to a high risk for oxidative damage because of its high dopamine content may be the reason for more pronounced nigral complex I deficiency compared to systemic organs. Oxidative stress and mitochondrial failure produce a vicious cycle in nigral neurons. To explore the genetic risk factors of sporadic PD, studies on familial PD and parkinsonism are important. Recently, an autosomal dominant form of familial PD was found to be caused by point mutations of the alpha-synuclein gene, and an autosomal recessive familial parkinsonism was mapped to the long arm of chromosome 6 near the Mn-SOD gene locus. Information obtained in these familial cases will contribute to the research on sporadic PD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9749580     DOI: 10.1002/ana.410440715

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  24 in total

1.  Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease.

Authors:  V Viswanath; Y Wu; R Boonplueang; S Chen; F F Stevenson; F Yantiri; L Yang; M F Beal; J K Andersen
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

2.  alpha-synuclein promotes mitochondrial deficit and oxidative stress.

Authors:  L J Hsu; Y Sagara; A Arroyo; E Rockenstein; A Sisk; M Mallory; J Wong; T Takenouchi; M Hashimoto; E Masliah
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 3.  The genetic basis of Parkinson's disease.

Authors:  T Foltynie; S Sawcer; C Brayne; R A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

Review 4.  Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress.

Authors:  Laszlo Tretter; Vera Adam-Vizi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

Review 5.  Laboratory approach to mitochondrial diseases.

Authors:  D Parra; A González; C Mugueta; A Martínez; I Monreal
Journal:  J Physiol Biochem       Date:  2001-09       Impact factor: 4.158

6.  Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification.

Authors:  Nelson B Cole; Diane Dieuliis; Paul Leo; Drake C Mitchell; Robert L Nussbaum
Journal:  Exp Cell Res       Date:  2008-03-28       Impact factor: 3.905

7.  Calpain inhibition protected spinal cord motoneurons against 1-methyl-4-phenylpyridinium ion and rotenone.

Authors:  S Samantaray; V H Knaryan; C Le Gal; S K Ray; N L Banik
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

8.  Coenzyme Q10 Prevents Mitochondrial Dysfunction and Facilitates Pharmacological Activity of Atorvastatin in 6-OHDA Induced Dopaminergic Toxicity in Rats.

Authors:  Santosh Kumar Prajapati; Debapriya Garabadu; Sairam Krishnamurthy
Journal:  Neurotox Res       Date:  2017-01-27       Impact factor: 3.911

Review 9.  Cellular and molecular mechanisms of Parkinson's disease: neurotoxins, causative genes, and inflammatory cytokines.

Authors:  Toshi Nagatsu; Makoto Sawada
Journal:  Cell Mol Neurobiol       Date:  2006-07-06       Impact factor: 5.046

10.  Enhancement of nicotinic receptors alleviates cytotoxicity in neurological disease models.

Authors:  Jun Kawamata; Syuuichirou Suzuki; Shun Shimohama
Journal:  Ther Adv Chronic Dis       Date:  2011-05       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.